morphine sulfate + oxycodone hydrochloride

Morphine sulfate + oxycodone hydrochloride is a combination of two opioid analgesics used for the management of moderate to severe pain when alternative treatment options are inadequate. Both components act primarily as agonists at the mu-opioid receptor in the central nervous system, resulting in analgesia, sedation, and euphoria. Morphine is a naturally occurring opiate derived from the poppy plant and acts mainly as a mu-opioid receptor agonist. Oxycodone is a semisynthetic opioid derived from thebaine and also acts predominantly on mu-opioid receptors but has some activity at kappa and delta receptors as well[1][3][5]. The combination may be considered in certain clinical scenarios to optimize pain control; however, evidence suggests that their coadministration does not produce synergistic antinociceptive effects in healthy humans[1]. Both drugs carry risks of dependence, tolerance, respiratory depression, constipation, and other opioid-related adverse effects.

Brand names

MS ContinKadianArymo ERMorphabond ERRoxanolOxyContinRoxicodoneOxaydoXtampza ER

Other names

morphine sulphate + oxycodone hydrochloride